The Effectiveness of Curcumin, Resveratrol, and Silymarin on MASLD : A Systematic Review and Meta‐Analysis
Food Science & Nutrition · 2024-12 · 12 (12) · 10010-10029
DOI: 10.1002/fsn3.4595 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Food Science & Nutrition, online erschienen am 14.11.2024. Verfasst von Qian Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Liver Diseases Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai China. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Polyphenols, known for their potent antioxidant and anti‐inflammatory properties, have emerged as promising, natural, and safe complementary treatment options for metabolic‐associated steatotic liver disease (MASLD). Among these, curcumin, resveratrol, and silymarin are the most extensively studied; however, their differential effects on MASLD outcomes remain inconclusive. This systematic review and meta‐analysis of RCTs aimed to evaluate the efficacy of curcumin, resveratrol, and silymarin in patients with MASLD. A comprehensive search of seven databases was conducted up to September 2024. Odds ratios (OR), mean differences (MD), and standardized MD (SMD) with 95% confidence intervals (CI) were used to assess treatment effects. Primary outcomes included improvement in hepatic steatosis and ALT activity, while secondary outcomes included changes in AST activity, blood lipids, glucose, BMI, blood pressure, and TNF‐α. Twenty‐seven studies involving 1691 participants were included. Curcumin significantly improved hepatic steatosis compared to placebo (OR: 4.39, 95% CI: 1.45 to 13.27, p = 0.009), followed by resveratrol (OR: 3.18, 95% CI: 1.20 to 8.42, p = 0.02). Silymarin exhibited the strongest effect in reducing ALT levels (MD: −6.44 U/L, 95% CI: −10.03 to −2.85, p = 0.0004), with curcumin (MD: −5.88 U/L, 95% CI: −9.05 to −2.72, p = 0.0003) also showing significant reductions. A marked reduction in AST was observed with silymarin (MD: −6.99 U/L, 95% CI: −8.56 to −5.42, p < 0.00001), followed by curcumin (MD: −3.36 U/L, 95% CI: −5.35 to −1.36, p = 0.001). Furthermore, curcumin intake significantly improved metabolic indicators (TG, FBG, HOMA‐IR, and BMI). Resveratrol reduced FBG and DBP. Curcumin had the strongest effect on hepatic steatosis and improved both transaminase levels and metabolic markers. Silymarin demonstrated the greatest reduction in transaminase levels, while resveratrol showed modest benefits in steatosis and metabolic improvements. The three polyphenols appear as promising therapeutics for the treatment of MASLD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Liver Diseases Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai China.
- School of Basic Medicine Shaanxi University of Chinese Medicine Xianyang Shaanxi China.
- Central Laboratory Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine of Shanghai Shanghai China.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai China.
- Institute of Anorectal Diseases Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai China.
- Shanghai Key Laboratory of Traditional Chinese Clinical Medicine Shanghai China.
ORCID-Profile: Qin Feng
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Huang, Q., An, Z., Xin, X., Gou, X., Tian, X., Hu, Y., Mei, Z., & Feng, Q. (2024). The Effectiveness of Curcumin, Resveratrol, and Silymarin on MASLD : A Systematic Review and Meta‐Analysis. Food Science & Nutrition, 12(12), 10010-10029. https://doi.org/10.1002/fsn3.4595
Vancouver
Huang Q, An Z, Xin X, Gou X, Tian X, Hu Y, et al. The Effectiveness of Curcumin, Resveratrol, and Silymarin on MASLD : A Systematic Review and Meta‐Analysis. Food Science & Nutrition. 2024;12(12):10010-10029. doi:10.1002/fsn3.4595
BibTeX
@article{Huang2024,
author = {Huang, Qian and An, Ziming and Xin, Xin and Gou, Xiaojun and Tian, Xiaoting and Hu, Yiyang and Mei, Zubing and Feng, Qin},
title = {The Effectiveness of Curcumin, Resveratrol, and Silymarin on MASLD : A Systematic Review and Meta‐Analysis},
journal = {Food Science & Nutrition},
year = {2024},
volume = {12},
number = {12},
pages = {10010--10029},
doi = {10.1002/fsn3.4595}
}
EUVIMED